Loading the session
Loading the session
Loading instrument
$56.09
+3.10%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +11.6% (SPY −1.6%, XLV +13.5%). 3 months: +108.2% (SPY −0.4%, XLV +15.5%). 1 year: +66.9% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: HTFL, SPY and XLV · as of 4 Nov 2026
Closed at $56.57 on 4 Nov 2026: 6.6% below the 52-week high of $60.56 (29 Oct 2026) and 181.0% above the low of $20.13 (13 Feb 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $56.57 was 10.6% above its 50-day average ($51.13) and 64.4% above its 200-day average ($34.41). It has closed above the 200-day for 62 sessions, since 10 Aug 2026. The 50-day average crossed above the 200-day on 14 Aug 2026, 57 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
7.3M shares were sold short at the 15 Oct 2026 settlement; covering them would take 4.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
August 14, 2026
+35.70%June 30, 2026
−15.81%February 12, 2026
−16.55%